Cargando…

Kidney Function and Estimated Vascular Risk in Patients with Primary Dyslipidemia

BACKGROUND: Chronic kidney disease (CKD) is associated with increased vascular risk. Some studies suggested that considering markers of CKD might improve the predictive accuracy of the Framingham risk equation. AIM: To evaluate the links between kidney function and risk stratification in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tziomalos, Konstantinos, Ganotakis, Emmanuel S, Gazi, Irene F, Nair, Devaki R, Mikhailidis, Dimitri P
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Open 2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2703830/ https://www.ncbi.nlm.nih.gov/pubmed/19572030 http://dx.doi.org/10.2174/1874192400903010057

Ejemplares similares

Dyslipidemia Induced by Drugs Used for the Prevention and Treatment of Vascular Diseases
por: Tziomalos, Konstantinos, et al.
Publicado: (2011)

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study
por: Athyros, Vassilios G., et al.
Publicado: (2011)

Assessing renal function – searching for the perfect marker continues!
por: Nair, Devaki R., et al.
Publicado: (2011)

Dyslipidaemia of Obesity, Metabolic Syndrome and Type 2 Diabetes Mellitus: the Case for Residual Risk Reduction After Statin Treatment
por: Athyros, Vasilios G, et al.
Publicado: (2011)

Ear lobe crease: a marker of coronary artery disease?
por: Agouridis, Aris P., et al.
Publicado: (2015)

Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?
por: Athyros, Vasilios G., et al.
Publicado: (2011)

Differences in metabolic parameters and cardiovascular risk between American Diabetes Association and World Health Organization definition of impaired fasting glucose in European Caucasian subjects: a cross-sectional study
por: Filippatos, Theodosios D., et al.
Publicado: (2013)

Epidemiology and Risk Factors for Stroke in Chronic Kidney Disease: A Narrative Review
por: Kourtidou, Christodoula, et al.
Publicado: (2023)

Novel Cardiovascular Risk Factors in Patients with Diabetic Kidney Disease
por: Kourtidou, Christodoula, et al.
Publicado: (2021)

Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients(§)
por: Athyros, Vasilios G, et al.
Publicado: (2007)

Narrative Review of Carotid disease and the kidney
por: Zanoli, Luca, et al.
Publicado: (2021)

The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease
por: Kourtidou, Christodoula, et al.
Publicado: (2023)

Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population
por: Kourtidou, Christodoula, et al.
Publicado: (2022)

IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis
por: Athyros, Vasilios G., et al.
Publicado: (2011)

Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study
por: Goyale, Atul, et al.
Publicado: (2021)

Atherogenic Dyslipidemia and Residual Vascular Risk in Practice of Family Doctor
por: Alibasic, Esad, et al.
Publicado: (2015)

Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study
por: Athyros, Vasilios G., et al.
Publicado: (2013)

Role of dyslipidemia in early vascular aging syndrome
por: KILIÇ 1, Alparslan, et al.
Publicado: (2021)

Blood pressure variability: Prognostic implications in low‐risk subjects
por: Kourtidou, Christina, et al.
Publicado: (2021)

Dyslipidemia Associated with Chronic Kidney Disease
por: Tsimihodimos, Vasilis, et al.
Publicado: (2011)

Patient with Hypertriglyceridemia, Type 2 Diabetes, and Chronic Kidney Disease Treated with Atorvastatin and Omega-3 Fatty Acid Ethyl Esters
por: Athyros, Vasilios G, et al.
Publicado: (2012)

Dietary Lipids and Dyslipidemia in Chronic Kidney Disease
por: Kochan, Zdzislaw, et al.
Publicado: (2021)

Characterization of Clinical and Genetic Risk Factors Associated with Dyslipidemia after Kidney Transplantation
por: Numakura, Kazuyuki, et al.
Publicado: (2015)

Primary vascular tumours of the kidney
por: Omiyale, Ayo O
Publicado: (2021)

Editorial: Cardiovascular diseases in autoimmune diseases: Dyslipidemia and vascular inflammation
por: Solow, E. Blair, et al.
Publicado: (2022)

Sodium-Glucose Co-Transporter 2 Inhibitors and Fracture Risk
por: Erythropoulou-Kaltsidou, Anastasia, et al.
Publicado: (2019)

Dyslipidemia, Insulin Resistance, Ectopic Lipid Accumulation, and Vascular Function in Resistance to Thyroid Hormone β
por: Moran, Carla, et al.
Publicado: (2021)

Association of Dyslipidemia with Renal Outcomes in Chronic Kidney Disease
por: Chen, Szu-Chia, et al.
Publicado: (2013)

Dyslipidemia After Kidney Transplantation and Correlation With Cyclosporine Level
por: Hosseini, Mahboobeh-Sadat, et al.
Publicado: (2013)

Thyroid dysfunction and dyslipidemia in chronic kidney disease patients
por: Khatiwada, Saroj, et al.
Publicado: (2015)

Dyslipidemia in patients with chronic kidney disease: etiology and management
por: Mikolasevic, Ivana, et al.
Publicado: (2017)

The Tacrolimus Metabolism Rate and Dyslipidemia after Kidney Transplantation
por: Thölking, Gerold, et al.
Publicado: (2021)

Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview
por: Suh, Sang Heon, et al.
Publicado: (2023)

Cholesterol, carotid artery disease and stroke: what the vascular specialist needs to know
por: Paraskevas, Kosmas I., et al.
Publicado: (2020)

Mixed dyslipidemias in primary care patients in France
por: Laforest, Laurent, et al.
Publicado: (2012)

Cardiovascular Risk Prediction Models and Scores in the Era of Personalized Medicine
por: Sofogianni, Areti, et al.
Publicado: (2022)

Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome
por: Tziomalos, Konstantinos, et al.
Publicado: (2018)

Effects of glucose-lowering agents on ischemic stroke
por: Avgerinos, Konstantinos, et al.
Publicado: (2017)

Iron Indices in Patients with Functional Anemia in Chronic Kidney Disease
por: Reddy, G. Chinnapu, et al.
Publicado: (2014)

Nutrition During Pregnancy and the Effect of Carbohydrates on the Offspring’s Metabolic Profile: In Search of the “Perfect Maternal Diet”
por: Tzanetakou, Irene P, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hn0rdu1a8e8lr58qmm61hp0ibs